Rema (Rao) Chaari (@raodyisms) 's Twitter Profile
Rema (Rao) Chaari

@raodyisms

An extroverted pathologist, podcaster, yoga enthusiast, BollyX instructor..and a classic ENFP!!! #cytopath #pathology

ID: 72322050

calendar_today07-09-2009 16:38:22

570 Tweet

640 Followers

554 Following

JClinPath_BMJ (@jclinpath_bmj) 's Twitter Profile Photo

🧪 Optimal 🥇CEA cutoff 📉 for diagnosing mucinous pancreatic cysts🥚 differs between assays💉 Beckman Coulter📟 cutoff 45.9 ng/mL🌡️ vs Siemens Centaur XP💻 cutoff 24.4 ng/mL🌡️ More studies needed to validate cutoffs across platforms! 🧬🌈💥🎉 bit.ly/3QW3Smj

🧪 Optimal 🥇CEA cutoff 📉 for diagnosing mucinous pancreatic cysts🥚 differs between assays💉 
Beckman Coulter📟 cutoff 45.9 ng/mL🌡️ 
vs Siemens Centaur XP💻 cutoff 24.4 ng/mL🌡️ 
More studies needed to validate cutoffs across platforms! 🧬🌈💥🎉
bit.ly/3QW3Smj
Vikram Deshpande (@vik_deshpandemd) 's Twitter Profile Photo

🚨 “Scott talks about his approach to diagnosing osteomyelitis!” 📢 When was the last time you heard someone break down an approach to osteomyelitis THIS well?! 🦴💥 This isn’t your everyday bone infection talk—Scott’s bringing the A-game, passion, and insights to the table!

Vikram Deshpande (@vik_deshpandemd) 's Twitter Profile Photo

🌆 Are you a resident or fellow in the New England area looking for a fine dinner and a side of brainy education? Look no further! Tonight from 6-8 PM: Hubert J. Wolfe, MD Lecture, sponsored by Tufts Medical Center: “Unfreeze Your Mind: Brain Tumors After Hours” 🧠 Speaker: Dr.

🌆 Are you a resident or fellow in the New England area looking for a fine dinner and a side of brainy education? Look no further! Tonight from 6-8 PM:
Hubert J. Wolfe, MD Lecture, sponsored by Tufts Medical Center:
“Unfreeze Your Mind: Brain Tumors After Hours”
🧠 Speaker: Dr.
Vikram Deshpande (@vik_deshpandemd) 's Twitter Profile Photo

An often-forgotten figure in the history of chemotherapy is Yellapragada Subbarow, the Indian chemist who discovered aminopterin, a folic acid antagonist. Aminopterin became one of the first chemotherapy agents used by Sidney Farber in the 1940s to induce remission in children

Cleveland Clinic Pathology Residency (@ccfpathres) 's Twitter Profile Photo

Happy Match Day! We’re excited to announce our new incoming residents! Welcome to the CCF family - we can’t wait to meet you in person soon! 😊🔬 #pathmatch #pathmatch2025

Happy Match Day! We’re excited to announce our new incoming residents! Welcome to the CCF family - we can’t wait to meet you in person soon! 😊🔬
#pathmatch #pathmatch2025
Scott Kilpatrick, MD (@scottbikeethan) 's Twitter Profile Photo

Dr. John Goldblum deservedly received the inaugural Chris Fletcher Award ⁦USCAP⁩ echoing the mentorship role he sought to emulate! Congrats John!

Vikram Deshpande (@vik_deshpandemd) 's Twitter Profile Photo

Controversial but crucial: The new WHO Blue Books heavily rely on molecular diagnostics, tools inaccessible to up to 80% of the world’s population. Instead of addressing global inequality, they risk deepening it. Radical, inclusive change is urgently needed.

Sanjay Mukhopadhyay (@smlungpathguy) 's Twitter Profile Photo

Vikram Deshpande Crucial to this approach is vastly overstating the value of NGS and targeted therapy. How many low grade neoplasms with a fusion do we need and how does it help the patient when they are all treated exactly the same?

Vikram Deshpande (@vik_deshpandemd) 's Twitter Profile Photo

Robert Homer Very true—but patients are aspirational, and so are their clinicians. People want the best, and the WHO has positioned itself as the gold standard in tumor classification. I’ve seen families willing to spend a lifetime’s savings on a single genetic test, just to give their child

Dr. Shalini Radhakrishnan (@shalinirkr21) 's Twitter Profile Photo

Vikram Deshpande I couldn't agree more! The WHO blue books, over the years, have become more glossy, hyper-specialized, and genetically obsessive; they now read like love letters to billion-dollar biotech firms. Problem is, the rest of the world isn’t reading along. Because we can't.

Scott Robertson (@scotrobertsonmd) 's Twitter Profile Photo

We built a fast web-based application for searching pathology reports. Works especially well with Epic data. Contact me if you want to learn more. #Pathology Manuscript Link: doi.org/10.1016/j.jpi.…

We built a fast web-based application for searching pathology reports. Works especially well with Epic data.  Contact me if you want to learn more. #Pathology 

Manuscript Link: 
doi.org/10.1016/j.jpi.…
Scott Kilpatrick, MD (@scottbikeethan) 's Twitter Profile Photo

If you decide to seek a second opinion for a life altering diagnosis, I highly recommend that you have your original pathology diagnosis, when applicable, also reviewed. At many institutions this is (and should be) standard practice.

JClinPath_BMJ (@jclinpath_bmj) 's Twitter Profile Photo

📊 The Area Under the Curve (AUC) is a single number that shows how well a model can tell categories apart. It combines sensitivity (finding true positives) and specificity (avoiding false positives) into one overall score. A perfect model has an AUC of 1.0—no missed diagnoses,

📊 The Area Under the Curve (AUC) is a single number that shows how well a model can tell categories apart. It combines sensitivity (finding true positives) and specificity (avoiding false positives) into one overall score. A perfect model has an AUC of 1.0—no missed diagnoses,
Cancer Cytopathology (@cancercytopath) 's Twitter Profile Photo

This review covers all relevant aspects of #telecytology for ROSE, including digital pathology options, operators, validation, quality assurance, reimbursement, and recommendations from professional organizations. 🌹 acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… MD Anderson Cancer Center #CytoPath

This review covers all relevant aspects of #telecytology for ROSE, including digital pathology options, operators, validation, quality assurance, reimbursement, and recommendations from professional organizations. 🌹 

acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

<a href="/MDAndersonNews/">MD Anderson Cancer Center</a> #CytoPath